Kemp B. Cease

4.5k citations

61 papers · 3.7k indexed · 2 hit papers · h-index 26

Virology top 1%
- HIV Research and Treatment 8
Immunology top 2%
- Immune Cell Function and Interaction 7
- T-cell and B-cell Immunology 7
Immunology and Allergy top 2%
Radiology, Nuclear Medicine and Imaging top 2%
- Monoclonal and Polyclonal Antibodies Research 8
Dermatology top 2%
Pulmonary and Respiratory Medicine
- Lung Cancer Diagnosis and Treatment 15
- Lung Cancer Treatments and Mutations 10
Molecular Biology
- vaccines and immunoinformatics approaches 10
- Bacillus and Francisella bacterial research 10

Co-authors: Jay A. Berzofsky James Cornette Charles DeLisi Hanah Margalit John L. Spouge Jon Oscherwitz Sara Brett Hiroaki Takahashi
Cited by: Virology Immunology Immunology and Allergy
Partner nations: United States China France

In The Last Decade

Kemp B. Cease

58 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2013 Staphylococcus δ-toxin induces allergic skin disease by activating mast cells
1987 Hydrophobicity scales and computational techniques for detecting amphipathic structures in proteins

Peers

Countries citing papers authored by Kemp B. Cease

Since Specialization

Citations

This map shows the geographic impact of Kemp B. Cease's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kemp B. Cease with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kemp B. Cease more than expected).

Fields of papers citing papers by Kemp B. Cease

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kemp B. Cease. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kemp B. Cease. The network helps show where Kemp B. Cease may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kemp B. Cease, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kemp B. Cease Line = papers co-authored together Kemp B. Cease links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer Feng‐Ming Kong,Randall K. Ten Haken,Matthew J. Schipper,Kirk A. Frey,James A. Hayman,Milton D. Gross,Nithya Ramnath,Khaled A. Hassan,M.M. Matuszak,Timothy Ritter,Nan Bi,Weili Wang,Mark B. Orringer,Kemp B. Cease,Theodore S. Lawrence,Gregory P. Kalemkerian	2017	9
2	Clinical Predictors of Durable Clinical Benefit of Pembrolizumab Therapy in Veterans With Metastatic Non–Small Cell Lung Cancer Angel Qin,Lorraine Street,Benjamin L. Viglianti,Kemp B. Cease,Edus H. Warren,Nithya Ramnath	2017	1
3	Identification and Validation of a Linear Protective Neutralizing Epitope in the β-Pore Domain of Alpha Toxin Jon Oscherwitz,Kemp B. Cease	2015	12
4	Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen Jon Oscherwitz,Conrad P. Quinn,Kemp B. Cease	2015	8
5	Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax Jon Oscherwitz,Daniel Feldman,Fen Yu,Kemp B. Cease	2014	5
6	A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer Nithya Ramnath,Stephanie Daignault‐Newton,Grace K. Dy,Josephia R. Muindi,Alex A. Adjei,V. L. Elingrod,Gregory P. Kalemkerian,Kemp B. Cease,Philip J. Stella,Dean E. Brenner,Sandra Troeschel,Candace S. Johnson,D L Trump	2013	23
7	Staphylococcus δ-toxin induces allergic skin disease by activating mast cellsbreakdown → Yuumi Nakamura,Jon Oscherwitz,Kemp B. Cease,Susana M. Chan,Raúl Muñoz-Planillo,Mizuho Hasegawa,Amer E. Villaruz,Gordon Y. C. Cheung,Martin J. McGavin,Jeffrey B. Travers,Michaël Otto,Naohiro Inohara,Gabriel Núñez	2013	409
8	A CD20 tandem-epitope immunogen elicits antibody in mice that binds murine cell surface CD20 and depletes splenic B cells in vivo☆ Jon Oscherwitz,Thomas Gribbin,Kemp B. Cease	2010	6
9	A Heterologous Helper T-Cell Epitope Enhances the Immunogenicity of a Multiple-Antigenic-Peptide Vaccine Targeting the Cryptic Loop-Neutralizing Determinant ofBacillus anthracisProtective Antigen Jon Oscherwitz,Fen Yu,Kemp B. Cease	2009	20
10	Genetic Vaccines for Anthrax Based on Recombinant Adeno-associated Virus Vectors Te-Hui Liu,Jon Oscherwitz,Bruce C. Schnepp,Jana L. Jacobs,Fen Yu,Kemp B. Cease,Philip R. Johnson	2008	16
11	Low-dose intraperitoneal Freund's adjuvant: Toxicity and immunogenicity in mice using an immunogen targeting amyloid-β peptide Jon Oscherwitz,F. Claire Hankenson,Fen Yu,Kemp B. Cease	2005	30
12	A V3 loop haptenic peptide sequence, when tandemly repeated, enhances immunogenicity by facilitating helper T-cell responses to a covalently linked carrier protein Jon Oscherwitz,Mary E. Zeigler,Thomas Gribbin,Kemp B. Cease	1999	14
13	Optimized PCR using Vent polymerase. Kemp B. Cease,C A Potcova,Cortland Lohff,Mary E. Zeigler	1994	6
14	Enhancement of lymphocyte proliferation assays by use of serum-free medium Eric Kaldjian,Gwo-Hsiao Chen,Kemp B. Cease	1992	26
15	HSP27 is a mediator of sustained smooth muscle contraction in response to bombesin Khalil N. Bitar,Mark Kaminski,Nabil Hailat,Kemp B. Cease,John R. Strahler	1991	109
16	Peptide Component Vaccine Engineering: Targeting the AIDS Virus Kemp B. Cease	1990	18
17	T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restriction P Hale,Kemp B. Cease,Richard A. Houghten,Chih-Wen Ou-Yang,Scott D. Putney,Kashi Javaherian,H. Margallt,James Cornette,John L. Spouge,Charles DeLisl,Jay A. Berzofsky	1989	63
18	Limiting dilution comparison of the repertoires of high and low responder MHC-restricted T cells. M. Kojima,Kemp B. Cease,G K Buckenmeyer,Jay A. Berzofsky	1988	37
19	Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans Jay A. Berzofsky,Armand Bensussan,Kemp B. Cease,Jean François Bourge,Rémi Cheynier,Z Lurhuma,J.J. Salaun,Robert C. Gallo,Gene M. Shearer,Daniel Zaguryi	1988	125
20	Protein Antigenic Structures Recognized by T Cells; Potential Applications to Vaccine Design Jay A. Berzofsky,Kemp B. Cease,James Cornette,John L. Spouge,Hanah Margalit,Ira Berkower,Michael F. Good,Louis H. Miller,Charles DeLisi	1987	121

About Kemp B. Cease

Kemp B. Cease is a scholar working on Virology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 61 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (15 papers), vaccines and immunoinformatics approaches (10 papers), Lung Cancer Treatments and Mutations (10 papers), Bacillus and Francisella bacterial research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), HIV Research and Treatment (8 papers), Immune Cell Function and Interaction (7 papers) and T-cell and B-cell Immunology (7 papers). The work is most often cited by research in Virology (708 citations), Immunology (1.3k citations) and Immunology and Allergy (251 citations). Kemp B. Cease has collaborated with scholars based in United States, China and France. Frequent co-authors include Jay A. Berzofsky, James Cornette, Charles DeLisi, Hanah Margalit, John L. Spouge, Jon Oscherwitz, Sara Brett, Hiroaki Takahashi, Anne Hosmalin and Ronald N. Germain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact